DEUTSCHE BANK AG\ - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 18 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$17,000
-19.0%
17,0000.0%0.00%
Q4 2020$21,000
+2000.0%
17,000
+1600.0%
0.00%
Q4 2019$1,0001,0000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Birch Grove Capital LP 8,000,000$5,215,0009.09%
BRAIDWELL LP 65,976,000$40,943,9961.29%
Context Capital Management, LLC 21,494$13,3291.07%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 30,500,000$20,663,7500.86%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 25,000,000$15,264,7310.24%
DeepCurrents Investment Group LLC 4,250,000$2,700,9940.12%
CAPSTONE INVESTMENT ADVISORS, LLC 7,500,000$4,654,4190.02%
Verition Fund Management LLC 1,359$843,3810.01%
LAZARD ASSET MANAGEMENT LLC 6,500,000$4,0330.01%
BLB&B Advisors, LLC 75,000$45,7940.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders